Heron Therapeutics Statistics
Total Valuation
HRTX has a market cap or net worth of $412.79 million. The enterprise value is $520.44 million.
| Market Cap | 412.79M |
| Enterprise Value | 520.44M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HRTX has 150.65 million shares outstanding. The number of shares has increased by 26.80% in one year.
| Shares Outstanding | 150.65M |
| Shares Change (YoY) | +26.80% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 0.70% |
| Owned by Institutions (%) | 80.47% |
| Float | 112.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.12 |
| Forward PS | 3.54 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.47
| Current Ratio | 2.47 |
| Quick Ratio | 1.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -159.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -37.20% |
| Return on Capital (ROIC) | -56.63% |
| Revenue Per Employee | $1.05M |
| Profits Per Employee | -$642,468 |
| Employee Count | 126 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +130.25% in the last 52 weeks. The beta is 1.81, so HRTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | +130.25% |
| 50-Day Moving Average | 3.17 |
| 200-Day Moving Average | 2.17 |
| Relative Strength Index (RSI) | 36.00 |
| Average Volume (20 Days) | 2,326,877 |
Short Selling Information
The latest short interest is 30.47 million, so 20.22% of the outstanding shares have been sold short.
| Short Interest | 30.47M |
| Short Previous Month | 30.04M |
| Short % of Shares Out | 20.22% |
| Short % of Float | 27.15% |
| Short Ratio (days to cover) | 14.20 |
Income Statement
In the last 12 months, HRTX had revenue of $132.10 million and -$80.95 million in losses. Loss per share was -$0.59.
| Revenue | 132.10M |
| Gross Profit | 75.40M |
| Operating Income | -82.35M |
| Pretax Income | -80.95M |
| Net Income | -80.95M |
| EBITDA | -77.58M |
| EBIT | -80.45M |
| Loss Per Share | -$0.59 |
Balance Sheet
The company has $71.52 million in cash and $179.17 million in debt, giving a net cash position of -$107.65 million or -$0.71 per share.
| Cash & Cash Equivalents | 71.52M |
| Total Debt | 179.17M |
| Net Cash | -107.65M |
| Net Cash Per Share | -$0.71 |
| Equity (Book Value) | -33.77M |
| Book Value Per Share | -0.22 |
| Working Capital | 110.53M |
Cash Flow
In the last 12 months, operating cash flow was -$43.41 million and capital expenditures -$1.31 million, giving a free cash flow of -$44.71 million.
| Operating Cash Flow | -43.41M |
| Capital Expenditures | -1.31M |
| Free Cash Flow | -44.71M |
| FCF Per Share | -$0.30 |
Margins
Gross margin is 57.08%, with operating and profit margins of -62.34% and -61.28%.
| Gross Margin | 57.08% |
| Operating Margin | -62.34% |
| Pretax Margin | -61.28% |
| Profit Margin | -61.28% |
| EBITDA Margin | -58.73% |
| EBIT Margin | -60.90% |
| FCF Margin | -33.85% |
Dividends & Yields
HRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.80% |
| Shareholder Yield | -26.80% |
| Earnings Yield | -19.61% |
| FCF Yield | -10.83% |
Analyst Forecast
The average price target for HRTX is $6.00, which is 118.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 118.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 18.78% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 13, 2014. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jan 13, 2014 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
HRTX has an Altman Z-Score of -11.29 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.29 |
| Piotroski F-Score | 4 |